Matthew Fust
Angel · California
Verified active in the last 12 months
Board director at 5 startups that filed Form D raises since late 2024, mostly in California.
- Stages
- Growth
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Oct 2025
Focus
Biotech & PharmaRecent portfolio activity
Sources
- SEC Form D: Neumora TherapeuticsJan 3, 2023
- SEC Form D: Crinetics PharmaceuticalsMar 11, 2024
- SEC Form D: Arsenal BiosciencesSep 4, 2024
- SEC Form D: Star TherapeuticsOct 6, 2025
- SEC Form D: Electra TherapeuticsOct 30, 2025
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.